• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激酶抑制剂片段的选择性。

Selectivity of kinase inhibitor fragments.

机构信息

GlaxoSmithKline R&D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.

出版信息

J Med Chem. 2011 Jul 28;54(14):5131-43. doi: 10.1021/jm200349b. Epub 2011 Jun 23.

DOI:10.1021/jm200349b
PMID:21699136
Abstract

A kinase-focused screening set of fragments has been assembled and has proved successful for the discovery of ligand-efficient hits against many targets. Here we present some of our general conclusions from this exercise. Notably, we present the first profiling results for literature fragments that have previously been used as starting points for optimization against individual kinases. We consider the importance of screening format and the extent to which selectivity is helpful in selecting fragments for progression. Results are also outlined for fragments targeting the DFG-out conformation and for atypical kinases such as PIM1 and lipid kinases.

摘要

激酶为靶点的小分子文库筛选已经建立,并在发现针对许多靶点的高效配体小分子方面取得了成功。在这里,我们将展示从这项工作中得出的一些普遍结论。值得注意的是,我们首次提供了文献报道的小分子片段的初步筛选结果,这些片段之前曾被用作针对个别激酶进行优化的起始点。我们考虑了筛选模式的重要性,以及在选择用于进展的片段时选择性的帮助程度。同时还概述了针对 DFG-out 构象的片段和非典型激酶(如 PIM1 和脂质激酶)的结果。

相似文献

1
Selectivity of kinase inhibitor fragments.激酶抑制剂片段的选择性。
J Med Chem. 2011 Jul 28;54(14):5131-43. doi: 10.1021/jm200349b. Epub 2011 Jun 23.
2
Trends in kinase selectivity: insights for target class-focused library screening.激酶选择性趋势:针对靶标类别聚焦文库筛选的见解。
J Med Chem. 2011 Jan 13;54(1):54-66. doi: 10.1021/jm101195a. Epub 2010 Dec 3.
3
Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.使用Free-Wilson定量构效关系分析预测激酶选择性概况。
J Chem Inf Model. 2008 Sep;48(9):1851-67. doi: 10.1021/ci800138n. Epub 2008 Aug 22.
4
Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.用于生成激酶靶向文库的对接策略的开发与实验验证。
J Med Chem. 2008 Jun 12;51(11):3124-32. doi: 10.1021/jm701367r. Epub 2008 May 15.
5
A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.一项晶体学片段筛选将肉桂酸衍生物鉴定为强效Pim-1抑制剂的起始点。
Acta Crystallogr D Biol Crystallogr. 2011 Mar;67(Pt 3):156-66. doi: 10.1107/S0907444910054144. Epub 2011 Feb 15.
6
Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases.基尼系数:一种表达激酶抑制剂对激酶家族选择性的新方法。
J Med Chem. 2007 Nov 15;50(23):5773-9. doi: 10.1021/jm070562u. Epub 2007 Oct 19.
7
Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.激酶-核模型:对整个人类激酶组中的 400 万种化合物进行准确的计算机筛选。
J Chem Inf Model. 2012 Jan 23;52(1):156-70. doi: 10.1021/ci200314j. Epub 2012 Jan 6.
8
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.激酶组空间化学覆盖范围的评估及其对激酶药物发现的影响。
J Med Chem. 2008 Dec 25;51(24):7898-914. doi: 10.1021/jm8011036.
9
Identification of pyrrolo[2,3-g]indazoles as new Pim kinase inhibitors.鉴定吡咯并[2,3-g]吲唑类化合物为新型 Pim 激酶抑制剂。
Bioorg Med Chem Lett. 2013 Apr 15;23(8):2298-301. doi: 10.1016/j.bmcl.2013.02.074. Epub 2013 Feb 26.
10
Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.激酶抑制剂数据建模与基于片段方法的全新抑制剂设计
J Med Chem. 2009 Oct 22;52(20):6456-66. doi: 10.1021/jm901147e.

引用本文的文献

1
Advances in Cancer Therapy: A Comprehensive Review of CDK and EGFR Inhibitors.癌症治疗的进展:CDK 和 EGFR 抑制剂的综合综述。
Cells. 2024 Oct 6;13(19):1656. doi: 10.3390/cells13191656.
2
Molecular basis for differential recognition of an allosteric inhibitor by receptor tyrosine kinases.别构抑制剂被受体酪氨酸激酶差异化识别的分子基础。
Proteins. 2024 Aug;92(8):905-922. doi: 10.1002/prot.26685. Epub 2024 Mar 20.
3
E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology.
E3 连接酶:遇见它们的“命中注定”——基于片段的方法发现新的 E3 配体并揭示 E3 生物学。
J Med Chem. 2023 Mar 9;66(5):3173-3194. doi: 10.1021/acs.jmedchem.2c01882. Epub 2023 Feb 23.
4
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set.阿斯利康的片段筛选:开发下一代生物物理片段集。
RSC Med Chem. 2022 Jul 4;13(9):1052-1057. doi: 10.1039/d2md00154c. eCollection 2022 Sep 21.
5
Discovery of a novel kinase hinge binder fragment by dynamic undocking.通过动态去对接发现一种新型激酶铰链结合片段
RSC Med Chem. 2020 Mar 4;11(5):552-558. doi: 10.1039/c9md00519f. eCollection 2020 May 1.
6
Systematic Assessment of Fragment Identification for Multitarget Drug Design.系统评估多靶标药物设计中的片段鉴定
ChemMedChem. 2021 Apr 8;16(7):1088-1092. doi: 10.1002/cmdc.202000858. Epub 2021 Feb 4.
7
Current Strategies and Applications for Precision Drug Design.精准药物设计的当前策略与应用
Front Pharmacol. 2018 Jul 18;9:787. doi: 10.3389/fphar.2018.00787. eCollection 2018.
8
Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition.基于 3-氨基吡啶-2-酮的激酶靶向片段文库的合成与分析:鉴定出 3-氨基-5-(4-吡啶基)吡啶-2(1H)-酮支架可抑制单极纺锤体 1(MPS1)和 Aurora 激酶。
Bioorg Med Chem. 2018 Jul 15;26(11):3021-3029. doi: 10.1016/j.bmc.2018.04.033. Epub 2018 Apr 17.
9
Twenty years on: the impact of fragments on drug discovery.二十年后:碎片对药物发现的影响。
Nat Rev Drug Discov. 2016 Sep;15(9):605-619. doi: 10.1038/nrd.2016.109. Epub 2016 Jul 15.
10
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.基于片段的强效和选择性DDR1/2抑制剂的发现
ACS Med Chem Lett. 2015 Jun 4;6(7):798-803. doi: 10.1021/acsmedchemlett.5b00143. eCollection 2015 Jul 9.